Legend Biotech Corporation (LEGN)
NASDAQ·Healthcare·Biotechnology
$23.66
+0.04%
Mkt Cap $1.77B
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$58.60
Range $24.00 – $75.00
Implied Upside
+147.7%
Consensus $58.60 vs current $23.66
NASDAQ·Healthcare·Biotechnology
$23.66
+0.04%
Mkt Cap $1.77B
No recent rating data.
Price Target (28 analysts)
$58.60
Range $24.00 – $75.00
+147.7%
Consensus $58.60 vs current $23.66